Piebald trait: Implication of kit mutation on in vitro melanocyte survival and on the clinical application of cultured epidermal autografts

Journal of Investigative Dermatology

Volumn 127, Issue 3, 2007, Pages 676-686

  Bondanza, Sergio ^a   Bellini, Melissa ^b   Roversi, Gaia ^b   Raskovic, Desanka ^a   Maurelli, Riccardo ^a   Paionni, Emanuel ^a   Paterna, Patrizia ^a   Dellambra, Elena ^a   Larizza, Lidia ^b   Guerra, Liliana ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CELL LOSS; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; EPIDERMIS CELL; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MALE; MELANOCYTE; PATHOGENESIS; PHENOTYPE; PIEBALDISM; PRIORITY JOURNAL; SENESCENCE; SKIN AUTOGRAFT; SKIN PIGMENTATION;

ADOLESCENT; ADULT; CELL SURVIVAL; CHILD; EPIDERMIS; FEMALE; HUMANS; MALE; MELANOCYTES; MUTATION; PHENOTYPE; PIEBALDISM; PIGMENTATION; PROTO-ONCOGENE PROTEINS C-KIT; SKIN TRANSPLANTATION;

EID: 33847011379     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700639     Document Type: Article

References (39)

1. Alexeev V, Yoon K (2006) Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol 126:1102-10
2. Barrandon Y, Green H (1987) Three clonal types of keratinocytes with different capacities for multiplication. Proc Natl Acad Sci USA 84:2302-6
3. Botchkareva NV, Khlgatian M, Longley BJ, Botchkarev VA, Gilchrest BA (2001) SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J 15:645-58
4. Brenner M, Degitz K, Besch R, Berking C (2005) Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation. Br J Dermatol 153:733-9
5. Dellambra E, Golisano O, Bondanza S, Siviero E, Lacal P, Molinari M et al. (2000) Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol 149:1117-30
6. De Luca M, Bondanza S, Di Marco E, Marchisio PC, D'Anna F, Franzi AT et al. (1994) Keratinocyte-melanocyte interactions in in vitro reconstituted normal human epidermis. In: The Keratinocyte Handbook. (Leigh I, Lane B and Watt F, eds), Cambridge: Cambridge University Press, 95-108
7. De Luca M, Franzi AT, D'Anna F, Zicca A, Albanese E, Bondanza S et al. (1988) Coculture of human keratinocytes and melanocytes: differentiated melanocytes are physiologically organized in the basal layer of the cultured epithelium. Eur J Cell Biol 46:176-80
8. Ezoe K, Holmes SA, Ho L, Bennett CP, Bolognia JL, Brueton L et al. (1995) Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism. Am J Hum Genet 56:58-66
9. Falabella R, Barona MI, Escobar C, Borrero I, Arrunategui A (1995) Surgical combination therapy for vitiligo and piebaldism. Dermatol Surg 21:852-7
10. Giebel LB, Strunk KM, Holmes SA, Spritz RA (1992) Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 7:2207-17
11. Grichnik JM, Burch JA, Burchette J, Shea CR (1998) The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 111:233-8
12. Grichnik JM (2006) Kit and melanocyte migration. J Invest Dermatol 126:945-7
13. Guerra L, Capurro S, Melchi F, Primavera G, Bondanza S, Cancedda R et al. (2000) Treatment of stable vitiligo by TIMED surgery and transplantation of cultured epidermal autografts. Arch Dermatol 136:1380-9
14. Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S et al. (2003) Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol 139:1303-10
15. Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S et al. (2004) Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis. Br J Dermatol 150:715-21
16. Ito M, Kawa Y, Ono H, Okura M, Baba T, Kubota Y et al. (1999) Removal of stem cell factor or addition of monoclonal anti-c-KIT antibody induces apoptosis in murine melanocyte precursor. J Invest Dermatol 112:796-801
17. Kumagai N, Uchikoshi T (1997) Treatment of extensive hypomelanosis with autologous cultured epithelium. Ann Plast Surg 39:68-73
18. Kunisada T, Lu S-Z, Yoshida H, Nishikawa S, Nishikawa S-i, Mizoguchi M et al. (1998) Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J Exp Med 187:1565-73
19. Kunisada T, Yamazaki H, Hayashi S-I (2001) Ligands for receptor tyrosine kinases expressed in the skin as environmental factors for melanocytes development. J Investig Dermatol Symp Proc 6:6-9
20. Longley BJ, Morganroth GS, Tyrrel L, Gang Ding T, Anderson DM, Williams DE et al. (1993) Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. New Engl J Med 328:1302-7
21. Mancini A, Koch A, Stefan M, Niemann H, Tamura T (2000) The direct association of the multiple PDZ domain containing proteins (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase activity. FEBS Lett 482:54-8
22. Maurelli R, Zambruno G, Guerra L, Abruzzese C, Gellini M, Bondanza S et al. (2006) Inactivation of p16INK4a immortalizes primary human keratinocytes by maintaining cells in the stem cell compartment. FASEB J 20:1516-8
23. Munro J, Stott FJ, Vousden KH, Peters G, Parkinson EK (1999) Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization. Cancer Res 59:2516-21
24. Murakami T, Fukai K, Oiso N, Hosomi N, Kato A, Garganta C et al. (2004) New KIT mutations in patients with piebaldism. J Dermatol Sci 35:29-33
25. Murakami T, Hosomi N, Oiso N, Giovannucci-Uzielli ML, Aquaron R, Mizoguchi M et al. (2005) Analysis of KIT, SCF, and initial screening of SLUG in patients with piebaldism. J Invest Dermatol 124:670-2
26. Njoo MD, Nieuweboer-Krobotova L, Westerhof W (1998) Repigmentation of leucodermic defects in piebaldism by dermabrasion and thin splitthickness skin grafting in combination with minigrafting. Br J Dermatol 139:829-33
27. Okazaki M, Yoshimura K, Uchida G, Harii K (2005) Correlation between age and the secretion of melanocyte-stimulating cytokines in cultured keratinocytes and fibroblasts. Br J Dermatol 153(Suppl 2):23-9
28. Olsson MJ, Juhlin L (2002) Long-term follow-up of leukoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension. Br J Dermatol 147:893-904
29. Pellegrini G, Ranno R, Stracuzzi G, Bondanza S, Guerra L, Zambruno G et al. (1999) The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 68:868-79
30. Peters EM, Maurer M, Botchkarev VA, Jensen K, Welker P, Scott GA et al. (2003) Kit is expressed by epithelial cells in vivo. J Invest Dermatol 121:976-84
31. Rheinwald JG, Hahn WC, Ramsey MR, Wu JY, Guo Z, Tsao H et al. (2002) A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol 22:5157-72
32. Rochat A, Kobayashi K, Barrandon Y (1994) Location of stem cells of human hair follicles by clonal analysis. Cell 76:1063-73
33. Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y (2000) Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation 70:1588-98
34. Seiberg M (2001) Keratinocyte-melanocyte interactions during melanosome transfer. Pigm Cell Res 14:236-42
35. Spritz RA (1997) Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development. Semin Cutan Med Surg 16:15-23
36. Spritz RA (2006) Out, damned spot!. J Invest Dermatol 126:949-51
37. Spritz RA, Ho L, Strunk KM (1994) Inhibition of proliferation of human melanocytes by a KIT antisense oligodeoxynucleotide: implications for human piebaldism and mouse dominant white spotting (W). J Invest Dermatol 103:148-50
38. Spritz RA, Holmes SA, Ramesar R, Greenberg J, Curtis D, Beighton P (1992) Mutations of the KIT (mast/stem cell growth factor receptor) protooncogene account for a continuous range of phenotypes in human piebaldism. Am J Hum Genet 51:1058-65
39. Vancoillie G, Lambert J, Naeyaert J-M (1999) Melanocyte biology and its implications for the clinician. Eur J Dermatol 9:241-51